331 related articles for article (PubMed ID: 35295010)
1. Cardiac morbidity & mortality in patients with breast cancer: A review.
Dhir AA; Sawant SP
Indian J Med Res; 2021 Aug; 154(2):199-209. PubMed ID: 35295010
[TBL] [Abstract][Full Text] [Related]
2. New Insights on the Toxicity on Heart and Vessels of Breast Cancer Therapies.
Lanza O; Ferrera A; Reale S; Solfanelli G; Petrungaro M; Tini Melato G; Volpe M; Battistoni A
Med Sci (Basel); 2022 May; 10(2):. PubMed ID: 35736347
[TBL] [Abstract][Full Text] [Related]
3. Cardiotoxicity screening of long-term, breast cancer survivors-The CAROLE (Cardiac-Related Oncologic Late Effects) Study.
Puckett LL; Saba SG; Henry S; Rosen S; Rooney E; Filosa SL; Gilbo P; Pappas K; Laxer A; Eacobacci K; Kapyur AN; Robeny J; Musial S; Chaudhry A; Chaudhry R; Lesser ML; Riegel A; Ramoutarpersaud S; Rahmani N; Shah A; Papas V; Dawodu T; Charlton J; Knisely JPS; Lee L
Cancer Med; 2021 Aug; 10(15):5051-5061. PubMed ID: 34245128
[TBL] [Abstract][Full Text] [Related]
4. Breast Cancer Survivorship and Cardiovascular Disease: Emerging Approaches in Cardio-Oncology.
Xie Y; Collins WJ; Audeh MW; Shiao SL; Gottlieb RA; Goodman MT; Merz CN; Mehta PK
Curr Treat Options Cardiovasc Med; 2015 Dec; 17(12):60. PubMed ID: 26490280
[TBL] [Abstract][Full Text] [Related]
5. Prevention, Monitoring, and Management of Cardiac Dysfunction in Patients with Metastatic Breast Cancer.
Curigliano G; de Azambuja E; Lenihan D; Calabrò MG; Cardinale D; Cipolla CM
Oncologist; 2019 Nov; 24(11):e1034-e1043. PubMed ID: 31064888
[TBL] [Abstract][Full Text] [Related]
6. Cardiotoxicities of Non-Chemotherapeutic Metastatic Breast Cancer Treatments.
Soltani M; Sokoloff LJ; Fradley MG
Curr Oncol Rep; 2023 Aug; 25(8):923-935. PubMed ID: 37249834
[TBL] [Abstract][Full Text] [Related]
7. Management of Cardiovascular Disease in Women With Breast Cancer.
Barish R; Lynce F; Unger K; Barac A
Circulation; 2019 Feb; 139(8):1110-1120. PubMed ID: 30779651
[TBL] [Abstract][Full Text] [Related]
8. Clinical experience of a cardio-oncology consultation at a tertiary university hospital in Portugal: An observational study.
Fiuza M; Magalhães A; Nobre Menezes M; Costa P; Abreu Ribeiro L; Abreu C; Brás R; Vieira J; Duarte AI; Morais P; Silva B; Costa L; Pinto FJ
Rev Port Cardiol; 2022 Dec; 41(12):979-984. PubMed ID: 36153294
[TBL] [Abstract][Full Text] [Related]
9. Personalized Decision Making in Early Stage Breast Cancer: Applying Clinical Prediction Models for Anthracycline Cardiotoxicity and Breast Cancer Mortality Demonstrates Substantial Heterogeneity of Benefit-Harm Trade-off.
Upshaw JN; Ruthazer R; Miller KD; Parsons SK; Erban JK; O'Neill AM; Demissei B; Sledge G; Wagner L; Ky B; Kent DM
Clin Breast Cancer; 2019 Aug; 19(4):259-267.e1. PubMed ID: 31175052
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular Toxicities in Pediatric Cancer Survivors.
Ryan TD; Nagarajan R; Godown J
Cardiol Clin; 2019 Nov; 37(4):533-544. PubMed ID: 31587793
[TBL] [Abstract][Full Text] [Related]
11. Exercise as a diagnostic and therapeutic tool for preventing cardiovascular morbidity in breast cancer patients- the BReast cancer EXercise InTervention (BREXIT) trial protocol.
Foulkes SJ; Howden EJ; Antill Y; Loi S; Salim A; Haykowsky MJ; Daly RM; Fraser SF; La Gerche A
BMC Cancer; 2020 Jul; 20(1):655. PubMed ID: 32664946
[TBL] [Abstract][Full Text] [Related]
12. Evaluation and management of chemotherapy-induced cardiotoxicity in breast cancer: a Delphi study.
Gavila J; Seguí MÁ; Calvo L; López T; Alonso JJ; Farto M; Sánchez-de la Rosa R
Clin Transl Oncol; 2017 Jan; 19(1):91-104. PubMed ID: 27101413
[TBL] [Abstract][Full Text] [Related]
13. Cardiotoxicity of Agents Used in Patients With Breast Cancer.
Zagami P; Trapani D; Nicolò E; Corti C; Valenza C; Criscitiello C; Curigliano G; Carey LA
JCO Oncol Pract; 2024 Jan; 20(1):38-46. PubMed ID: 37983586
[TBL] [Abstract][Full Text] [Related]
14. Cardioprotective strategies to prevent breast cancer therapy-induced cardiotoxicity.
Padegimas A; Clasen S; Ky B
Trends Cardiovasc Med; 2020 Jan; 30(1):22-28. PubMed ID: 30745071
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular Disease and Breast Cancer: Where These Entities Intersect: A Scientific Statement From the American Heart Association.
Mehta LS; Watson KE; Barac A; Beckie TM; Bittner V; Cruz-Flores S; Dent S; Kondapalli L; Ky B; Okwuosa T; Piña IL; Volgman AS;
Circulation; 2018 Feb; 137(8):e30-e66. PubMed ID: 29437116
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy-induced cardiotoxicity in children.
Bansal N; Amdani S; Lipshultz ER; Lipshultz SE
Expert Opin Drug Metab Toxicol; 2017 Aug; 13(8):817-832. PubMed ID: 28679288
[TBL] [Abstract][Full Text] [Related]
17. Exercise to Reduce Anthracycline-Mediated Cardiovascular Complications in Breast Cancer Survivors.
Varghese SS; Johnston WJ; Eekhoudt CR; Keats MR; Jassal DS; Grandy SA
Curr Oncol; 2021 Oct; 28(5):4139-4156. PubMed ID: 34677269
[TBL] [Abstract][Full Text] [Related]
18. Tailored to a Woman's Heart: Gender Cardio-Oncology Across the Lifespan.
Chen MH; Epstein SF
Curr Cardiol Rep; 2023 Nov; 25(11):1461-1474. PubMed ID: 37819431
[TBL] [Abstract][Full Text] [Related]
19. Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management.
Curigliano G; Cardinale D; Dent S; Criscitiello C; Aseyev O; Lenihan D; Cipolla CM
CA Cancer J Clin; 2016 Jul; 66(4):309-25. PubMed ID: 26919165
[TBL] [Abstract][Full Text] [Related]
20. Chronic cardiovascular toxicity in the older oncology patient population.
Findlay SG; Gill JH; Plummer R; DeSantis C; Plummer C
J Geriatr Oncol; 2019 Sep; 10(5):685-689. PubMed ID: 30733001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
